Filter Integrity Test Market Size

Filter Integrity Test Market Analysis

The filter integrity test market is expected to witness a CAGR of 4.6% during the forecast period.

The COVID-19 pandemic had a significant impact on the market studied. Due to the emergence of COVID-19, the demand for air filters increased globally. There was a rising awareness regarding air filtration, and the use of masks containing filters increased among the population. This increased awareness created a huge demand for the development of various types of filters and brought new research and innovation to the market. For instance, as per an article published in Springer Nature in October 2021, HEPA air cleaners or filters are a cheap and easy way to reduce the risk of airborne pathogens. And it was also mentioned in the article that when a cost-effective portable filter containing a HEPA filter was used in hospital settings in the United Kingdom, it efficiently screened SARS-CoV-2 and other disease-causing microorganisms from hospital air. Thus, such instances created a demand for the use of filters during the pandemic, which ultimately generated demand for filter integrity tests done to check the integrity of the filters. Therefore, owing to the factors mentioned above the pandemic had a considerable impact on the market studied and is expected to project a similar trend in the post-pandemic owing to increased awareness regarding filter integrity, as per the analysis.

Factors such as increasing demand for biopharmaceuticals and higher spending on research and development (R&D) activities majorly contribute to the studied market growth.

The number of manufacturers is increasing in the biopharmaceutical sector due to the increasing demand for biopharmaceuticals. As per an article published in FPHAR in August 2022, biopharmaceuticals are one of the potential achievements of the twenty-first century and are superior to chemical products in terms of disease management and treatment outcomes. Additionally, as per the source mentioned above, biopharmaceuticals contain few to no adverse effects, and they exert more activity and specificity than conventional drugs. In addition, the development of biopharmaceutical capabilities is typically considered a country's priority and an indicator of scientific advancement. Thus, investments in the development of biopharmaceuticals are heavily influenced by the high demand for their availability, ultimately requiring aseptic conditions for manufacturing. Thus, the demand for filters in such facilities is likely to rise owing to the aseptic conditions required, in turn boosting the installation and adoption of several filters. Such an increased demand for filters will boost the adoption of filter integrity tests across biopharmaceutical manufacturing companies, leading to market growth.

In addition, a few other sources reviewed stated that integrity testing is a non-destructive test that is directly tied to a filter's capacity to retain microorganisms and gives assurance of filter performance in the customer's process. Integrity testing enables manufacturers to satisfy auditor requirements while avoiding costly problems including product contamination, product losses, reprocessing, and production delays. Thus, the use of filter integrity tests is increasing among biopharmaceutical manufacturers. Hence, with the increasing demand for biopharmaceuticals, the demand for filter integrity testing is increasing, driving the studied market's growth.

Furthermore, market players are adopting various strategies, such as product launches, collaborations, acquisitions, mergers, and expansions, to increase market share and expand their presence. For instance, in December 2021, Pall Corporation, in association with Express Pharma, introduced its new Palltronic Flowstar V filter integrity test instrument in India. This instrument is a filter integrity test device that supports critical filtration steps and batch release while addressing good manufacturing practice (GMP) manufacturing demands. Such developments in the market are anticipated to fuel market growth over the forecast period.

Therefore, owing to increasing biopharmaceutical manufacturing and the continuous involvement of market players, the studied market is anticipated to witness growth over the forecast period. However, the high cost of tests is expected to hamper the market growth.